Vicarious Surgical Inc. (RBOT)
After hours:
Chart Events
Performance Outlook
| Previous Close | 3.0100 |
| Open | 2.9300 |
| Bid | 0.0000 x 1200 |
| Ask | 0.0000 x 800 |
| Day's Range | 2.8900 - 3.1700 |
| 52 Week Range | 1.6900 - 6.6300 |
| Volume | |
| Avg. Volume | 481,513 |
| Market Cap | 360.992M |
| Beta (5Y Monthly) | 0.75 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.1610 |
| Earnings Date | Aug 08, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.75 |
- Business Wire
Vicarious Surgical to Report Fourth Quarter and Full Year 2022 Financial Results on February 13, 2023
WALTHAM, Mass., January 30, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced it will report financial results for the fourth quarter and full year ended December 31, 2022 after the market closes on Monday, February 13, 2023. Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
- Business Wire
Vicarious Surgical Announces Changes to Board of Directors
WALTHAM, Mass., January 23, 2023--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, today announced the appointment of Victoria Carr-Brendel, Ph.D. to the Vicarious Surgical Board of Directors effective today, January 23, 2023. The Company also announced the resignation of technology-focused venture capitalist Phil Liang from the Vicarious Surgical Board of Directors ef
- Business Wire
Vicarious Surgical Completes Public Demonstration of Beta 2 Surgical Robotic System
WALTHAM, Mass., December 22, 2022--Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics company seeking to improve the cost, efficiency, and outcomes of surgical procedures, hosted the first public demonstration of its Beta 2 surgical robotic platform on December 6, 2022, highlighting the latest evolution of its differentiated technology and showcasing recent cadaveric testing. Supporting presentations by representatives from leading healthcare provider Uni
